Ngapas, Acmad N.

HRN: 28-10-22  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2025
CEFTRIAXONE 1G (VIAL)
11/12/2025
11/18/2025
IV
2 Grams
OD
Cap Lr
Waiting Final Action 
11/13/2025
CEFTRIAXONE 1G (VIAL)
11/13/2025
11/20/2025
IV
2g
OD
T/C Pneumothorax Right LF, PTB, Category I, Lost To Followup, To Rule Out PTB Relapse
Waiting Final Action 
11/24/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/24/2025
12/08/2025
IV
4.5g
Q6hr
CAP-HR
Checking Initial Appropriateness 
12/06/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/06/2025
12/12/2025
IVTT
2.25 G
Q6
Cap HR
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: